Pure Global
NCT06243016

Breaking Sitting With High-intensity Interval Training for Brain Health

Breaking Prolonged Sitting With High-intensity Interval Training to Improve Cognitive and Brain Health in Older Adults: A Pilot Feasibility Trial.
University of Illinois at Urbana-Champaign·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Aging
Drug/Device/Intervention
High-Intensity Interval Training (HIIT) Breaks to Sitting
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Illinois at Urbana-Champaign
Location
Urbana, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 31, 2024
End date
May 31, 2026
Enrollment
54 participants
Primary outcome

Change in task-evoked brain activity

Summary

This trial will examine whether interrupting 3.5 hours of sitting every 30 min with 6 min
 high intensity interval training (HIIT) breaks compared to light intensity interval training
 (LIIT) will improve brain health in cognitively normal older adults. This trial will test the
 feasibility of HIIT breaks to sitting. It will also address several important but unanswered
 questions: (1) Does interrupting sitting with short HIIT breaks improve frontoparietal
 function? (2) Can interrupting sitting with HIIT breaks improve cognitive functions?

ICD-10 classifications
Alzheimer diseaseAgenesis and underdevelopment of noseAgenesis of lungAdult-onset Still diseaseChoroidal degeneration
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06243016
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06243016 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Illinois at Urbana-Champaign and is currently Not yet recruiting. The study focuses on Aging. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.